Literature DB >> 3204101

Growth requirements, growth factor responsiveness, and growth factor secretion of three human embryonal carcinoma cell lines.

W Verbeek1, C Bokemeyer, H Falk, H J Schmoll.   

Abstract

The in vitro growth requirements of three human embryonal carcinoma cell lines (H 12.7, 2102 EP, 1428 A) were investigated. The basal medium DME/F12 supplemented with insulin, transferrin, and low-density and high-density lipoproteins was sufficient to support substantial multiplication of all three lines. The most efficient attachment factor was either fibronectin (for 2102 EP and 1428 A) or collagen type I (H 12.7). In a serum-free system the influence of epidermal growth factor (EGF), insulin-like growth factor I, multiplication stimulating activity (MSA), a platelet extract, and the glucocorticoids dexamethasone and hydrocortisone, as determined by the DNA synthesis rate of the cells, was generally minimal. However, the DNA synthesis rate of cell lines H 12.7 and 2102 EP was increased by MSA, and the line with the highest potential to differentiate (H 12.7) was stimulated by EGF. All three cell lines secreted growth factors in a heterologous stimulation assay. Insulin-like growth factors I and II were not part of the growth promoting activity. The inhibitory effect of a monoclonal anti-EGF antibody on the 3H-thymidine incorporation of cell line 2102 EP might indicate autocrine secretion of EGF or an EGF-like factor by this cell line.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3204101     DOI: 10.1007/bf00398176

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  Production of PDGF-like growth factors by embryonal carcinoma cells and binding of PDGF to their endoderm-like differentiated cells.

Authors:  A Rizzino; D F Bowen-Pope
Journal:  Dev Biol       Date:  1985-07       Impact factor: 3.582

2.  F.9 embryonal carcinoma cell calcitonin autocrine system: correlation between immunoreactive calcitonin secretion and calcitonin receptor number.

Authors:  E Binet; P Laurent; D Evain-Brion
Journal:  J Cell Physiol       Date:  1985-08       Impact factor: 6.384

3.  Characterization of an insulin-related factor secreted by a teratoma cell line.

Authors:  Y Yamada; G Serrero
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

4.  Multiplication-stimulating activity stimulates the multiplication of F9 embryonal carcinoma cells.

Authors:  L Nagarajan; S P Nissley; M M Rechler; W B Anderson
Journal:  Endocrinology       Date:  1982-04       Impact factor: 4.736

5.  Cell lines of human germinal cancer.

Authors:  J Casper; H J Schmoll; U Schnaidt; C Fonatsch
Journal:  Int J Androl       Date:  1987-02

6.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  M S Brown; S E Dana; J L Goldstein
Journal:  J Biol Chem       Date:  1974-02-10       Impact factor: 5.157

7.  Growth and differentiation of embryonal carcinoma cell line F9 in defined media.

Authors:  A Rizzino; C Crowley
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Human embryonal carcinoma cells express low levels of functional receptor for epidermal growth factor.

Authors:  C R Carlin; P W Andrews
Journal:  Exp Cell Res       Date:  1985-07       Impact factor: 3.905

9.  Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia.

Authors:  J Zapf; H Walter; E R Froesch
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

10.  Monoclonal antibody to human epidermal growth factor.

Authors:  D M Moriarity; R A Harper; B B Knowles; C R Savage
Journal:  Hybridoma       Date:  1983
View more
  1 in total

1.  Production and response of a human prostatic cancer line to transforming growth factor-like molecules.

Authors:  A MacDonald; G D Chisholm; F K Habib
Journal:  Br J Cancer       Date:  1990-10       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.